Alten R, Lorenz H-M, Mariette X, et al. Abatacept retention rates and prognostic factors of retention in patients with rheumatoid arthritis: 2-year results from the real-world ACTION study. EULAR 2017, FRI0245.
1,6 miljoen voor 4 projecten naar zeldzame reuma
dec 2022 | JIA, Sclerodermie, SLE